delta-Sarcoglycan Antibody (19G8) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-42662H
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Western Blot
Label
HRP
Antibody Source
Monoclonal Mouse IgG1b Kappa Clone # 19G8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for delta-Sarcoglycan Antibody (19G8) [HRP]
Immunogen
Recombinant human delta-Sarcoglycan (57-289aa) purified from E. coli
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1b Kappa
Applications for delta-Sarcoglycan Antibody (19G8) [HRP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: delta-Sarcoglycan
Alternate Names
35DAG, CMD1L, DAGD, deltaSarcoglycan, LGMD2F, SGCD
Gene Symbol
SGCD
Additional delta-Sarcoglycan Products
Product Documents for delta-Sarcoglycan Antibody (19G8) [HRP]
Product Specific Notices for delta-Sarcoglycan Antibody (19G8) [HRP]
This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...